Sorriso Pharmaceuticals, Inc. — Form D

Sorriso Pharmaceuticals, Inc. of SANDY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-11. The offering totals $31.4M, of which $21.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-01-11
• Form: D
• Accession: 0001903902-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $31.4M
• Amount sold: $21.3M
• Remaining: $10.1M
• Investors: 11
• Date of first sale: 2021-12-21
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-428887

Issuer

• Name: Sorriso Pharmaceuticals, Inc.
• CIK: 0001903902
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 6 NORTHRIDGE WAY, SANDY, UT, 84092
• Phone: (619) 733-3852

Officers, directors & promoters (7)

More

• CIK 1903902 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search